CTIS.eu › Cities › Denmark › Herlev
Herlev
Denmark
293 total trials
133 recruiting
2023-509665-20-00
1
2024-08-15
Locally advanced or metastatic melanoma
2023-509096-16-00
6
2024-07-31
Moderately to Severely Active Crohn’s Disease
2024-514900-16-00
6
2024-07-25
Gram-negative Bacteremia
2024-515001-26-00
6
2024-07-25
Blood poisoning in patients with renal failure treated with hemodialys
2023-507684-19-00
5
2024-07-24
FGFR+ Intermediate-risk Non-muscle Invasive Bladder Cancer
2023-504962-52-00
5
2024-07-10
Triple negative breast cancer.
2023-505794-32-04
5
2024-07-05
Type 1 diabetes
2023-506226-36-00
6
2024-06-23
Fungal infection
2023-507111-35-00
9
2024-06-03
Prostate Cancer
2024-512641-16-00
4
2024-04-15
Infectious pulmonary endotheliopathy
2023-503317-29-00
5
2024-04-12
Metastatic renal cell carcinoma (mRCC)
2023-507617-96-01
6
2024-02-14
Pyogenic vertebral osteomyelitis
2022-500531-36-00
4
2024-02-02
Type 1 diabetes mellitus
2022-502500-75-00
6
2024-01-30
Atrial fibrillation
2022-502456-31-00
1
2023-11-30
Advanced or metastatic solid tumors
2024-514291-41-00
4
2023-10-20
Pancreatic cancer
2022-500035-36-01
6
2023-09-14
Acute heart failure with pulmonary congestion
2024-517619-65-00
4
2023-08-28
Colon cancer
2022-502633-26-00
5
2023-08-25
Melanoma
Surgery
2022-503026-12-00
5
2023-08-22
Immune checkpoint inhibitor related colitis
2022-501006-34-01
5
2023-03-29
Liver cirrhosis
2022-500906-17-01
4
2023-03-21
Type 1 diabetes
2022-500646-14-00
4
2023-01-31
cancer
2022-500143-21-01
6
2023-01-12
Type 2 diabetes
Showing 121–144 of 293 trials